Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart …
F Zerbib, AJ Bredenoord, R Fass… - …, 2021 - Wiley Online Library
Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD) do not respond completely to proton pump inhibitor (PPI) therapy. The term “refractory …
VT Ivashkin, IV Maev, AS Trukhmanov… - Russian journal of …, 2020 - gastro-j.ru
Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease | Ivashkin | Russian Journal of …
Research for new therapies to treat diseases like cancer, it is one of the focus of Health Sciences. Nowadays, the available therapeutic strategies have in many cases limitations …
R Fass - New England Journal of Medicine, 2022 - Mass Medical Soc
Key Clinical Points Gastroesophageal Reflux Disease Patients with heartburn and symptoms such as dysphagia, odynophagia, weight loss, anorexia, gastrointestinal …
ВТ Ивашкин, АА Шептулин, ТЛ Лапина… - Российский журнал …, 2012 - gastro-j.ru
Вопросам функциональной диспепсии (ФД) в последние годы уделяется очень большое внимание. Различные аспекты этой актуальной проблемы постоянно обсуждаются в …
F Rettura, F Bronzini, M Campigotto, C Lambiase… - Frontiers in …, 2021 - frontiersin.org
Gastroesophageal reflux disease (GERD) is one of the most frequent gastrointestinal disorders. Proton pump inhibitors (PPIs) are effective in healing lesions and improving …
Gastro-esophageal reflux disease (GERD) is a highly prevalent, chronic disorder, whose knowledge remains limited and the management of these patients changes continuously …